跳至主要内容
临床试验/NCT01351142
NCT01351142已完成不适用

Cytokines and Cognitive Decline in Alzheimer's Disease

Poitiers University Hospital20 个研究点 分布在 1 个国家目标入组 133 人开始时间: 2009年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
133
试验地点
20

研究概览

简要总结

Amyloid plaques and neurofibrillary tangles are the 2 well-known etiopathological hallmarks of Alzheimer's disease (AD). Beside these 2 lesions, inflammation response is described in the brain of patients with AD.

The main objective of our study is to analyse the correlation between the value of plasma cytokines (interleukin 1, 6, TNFα and chemochine Rantes) and the rapidity of the cognitive decline in AD over a 2-year follow-up.

Secondary objectives include:

  • the predictive value of the cytokines on the cognitive decline after 6 months and one year of follow-up., of the patients include 150 patients with AD (MMSE: 16-25)
  • correlation between plasma cytokines levels and expression of the protein kinase PKR (involved in death cell) in blood mononuclear cells.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group

入排标准

性别
All
接受健康志愿者

入选标准

  • Alzheimer's disease (AD)patients
  • MMSE score: 16-25
  • Written informed consent

排除标准

  • AD patients with specific treatment for AD before inclusion MMSE score under 16 or over 25 at inclusion
  • patients with anti-inflammatory drugs (non steroids or corticosteroids) or immunosuppressive agents
  • Patients with acute disease (infectious disease, rheumatologic disease) or chronic disease (malignancy, infectious, rheumatologic disease) that could interact with plasma cytokines level
  • Patients with a life threatening disease

研究者

申办方类型
Other

研究点 (20)

Loading locations...

相似试验